ClinicalTrials.gg
CompletedNCT05474521Updated Jul 26, 2022

Evaluation of Illinois Agility Performance With Smartphone Applications: A Validity and Reliability Study

An interventional study of CODTimer test in Training Group and Sensitivity, sponsored by Mehmet Akif Ersoy University. Completed at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-07-26.

Sponsored by Mehmet Akif Ersoy University · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Mar 2022, registered Jul 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
18 Years to 25 Years
Sex
All
01

Study summary

Due to the impracticality of accessing the gold standard test devices, researchers have developed easy-to-use and cost-effective smartphone applications that do not require expert knowledge, and these applications have been used to measure different motor abilities. Smartphone applications such as CODtimer, Stopwatch Movie watch, and Seconds Count are used to evaluate the ability to change direction within these biomotor features. However, the validity and reliability of these applications are the subjects of research.

Read the detailed description

The athletic performance level is one of the main factors that determine the success of an athlete. However, the athletic performance level of an athlete is determined by many motor abilities. One of these motor abilities is agility.

Because agility has been seen as a complex physical skill, valid and reliable tests and test devices are needed to determine the level of agility. Therefore, researchers have developed many test devices using technology and they have aimed to reach gold standards to measure agility ability through these devices. In this context, manual timers were first used to measure agility performance, then devices such as fully automatic test devices, photocell types, video timers, and radar systems were accepted as a test tool for the measurement of agility performance. Although fully automatic test devices are accepted as the gold standard in the measurement of velocity-based parameters, they cannot be preferred by everyone due to obstacles such as the need for expert knowledge and being economically costly for their use.

Due to the impracticality of accessing the gold standard test devices, researchers have developed easy-to-use and cost-effective smartphone applications that do not require expert knowledge, and these applications have been used to measure different motor abilities. Among these motor features, CODTimer App is the smartphone application that is frequently preferred in the evaluation of agility ability and whose validity-reliability studies are conducted.

In the previous studies on the validity and reliability of the CODTimer App, a very strong correlation was found between the CODTimer App and the gold standard automatic timing gates according to the 5+5 and 505 agility test protocols. However, many mobile applications have validity and reliability unexplored. It is necessary to investigate different test protocols and devices to spread the use of mobile applications and prove that they are valid and reliable measurement tools.

This study aimed to determine the validity, reliability, and usefulness of the CODTimer, Second Count, and Stopwatch Moviewatch App with an iPhone 11 compared to gold standard timing gates for the evaluation of Illinois agility performance in college athletes.

02

Conditions studied

  • Training Group
  • Sensitivity

Browse trials for

Keywords

  • Performance test
  • Smarthone app
  • Agility
03

In context

Hypersensitivity

1,925 studies on the registry are indexed under Hypersensitivity; 261 are open to participants now.

This study's enrollment of 30 is below the median of 58 across 1,391 interventional studies indexed under Hypersensitivity.

Browse Hypersensitivity studies →

Lead sponsor

Mehmet Akif Ersoy University is the lead sponsor of 25 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Athletes who have not experienced an injury in the last 1 year and have a training history of at least one year.

Exclusion criteria

Exclusion Criteria:

  • Participants who do not meet the inclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Participant 1

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 2

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 3

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 4

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 5

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 6

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 7

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 8

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 9

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 10

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 11

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 12

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 13

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 14

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 15

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 16

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 17

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 18

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 19

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 20

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 21

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 22

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 23

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 24

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 25

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 26

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 27

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 28

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 29

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

  • Experimental
    Participant 30

    The participant applied the Illinois test twice to determine the validity, reliability, and usefulness of the data collection tools.

    Device: CODTimer test

Interventions

  • DeviceCODTimer test

    The Illinois test times of the participants will be measured with different phone applications that measure the change of direction performance, and each individual will perform the test twice.

    Also known as: Stopwatch Moviewatch App, Seconds Count, Stopwatch, Photocell

06

What researchers measure

Primary outcomes

  1. The relationship of smartphone apps versus gold standard measuring tool in measuring direction change performance

    Two photocell doors with a height of 1.5 meters and a distance of 2 meters were placed at the beginning and the end of the test. However, to take measurements with smartphone applications, video recordings were made with smartphones from a height of 1.5, 2 meters away from the photocell, parallel to the ending and starting points. To measure with the stopwatch, the researchers were positioned 1 meter next to the photocell at the endpoint. At the beginning of the test, the exit positions of the participants were standardized, and each participant applied the illinois test twice with three minutes of listening. The means of the obtained values were determined according to the following formula; (first trial time\[second\]+ second trial time\[second\])/2. Hypothesis tests were performed with trial time mean. It was assumed that the shorter the test times of the athletes, the better their performance.

    Time frame: 1-week

07

Study locations

2 sites
  • Burdur Mehmet Akif Ersoy University Faculty of Sport Science
    Burdur, Turkey (Türkiye)
  • Huseyin Sahin UYSAL
    Burdur, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2022 to primary completion in Jun 2022, 2 months.

Of 423 non-industry interventional studies with no phase under Hypersensitivity, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 2 months is below that.

Counting every sponsor, half of 481 studies reached it within 13 months; a quarter within 5 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2022
First posted
Jul 26, 2022
StartActual
Mar 10, 2022
Primary completionActual
Jun 2, 2022
CompletionActual
Jun 20, 2022
Last update
Jul 26, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 26, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05474521
Lead sponsor
Mehmet Akif Ersoy University
Responsible party
Huseyin Sahin UYSAL (Research Assistant, Mehmet Akif Ersoy University) — Principal investigator
First posted
Jul 26, 2022
Start date
Mar 10, 2022
Primary completion
Jun 2, 2022
Completion
Jun 20, 2022
Last update
Jul 26, 2022

Study contacts

Huseyin Sahin Uysal, Msc
study director · Burdur Mehmet Akif Ersoy University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion